Our Categories
Entrepreneurs
Tech
Talent
Energy
Oil & Gas
Mining
Health
Automotive
Aerospace
Finance & Fintech
Infrastructure
Sustainability
Professional Services
E-Commerce & Retail
Agribusiness & Food
Logistics
Mobility
Trade & Investment
Policy & Economy
Cybersecurity
AI, Cloud & Data
Chemicals
Multimedia
Podcast
Videos
Audio Articles
Opinion
Expert Contributor
Startup Contributor
Goverment
Embassy
Chamber of Commerce
Industry Association
Type
Spotlight
Entrepreneurs
Tech
Talent
Energy
Oil & Gas
Mining
Health
Automotive
Aerospace
Finance & Fintech
Infrastructure
Sustainability
Professional Services
E-Commerce & Retail
Agribusiness & Food
Logistics
Mobility
Trade & Investment
Policy & Economy
Cybersecurity
AI, Cloud & Data
Chemicals
Loading...
Loading...
Sector by:
Global Trials Will Test AI-Engineered Antibody for Severe Asthma
By
MBN Staff
- Mon, 12/01/2025 - 17:37
Therapeutics company Generate:Biomedicines will begin global Phase 3 trials of GB-0895, an AI-designed antibody for severe asthma.
Featured content
Most popular
Partnership Content
Sector by:
